Alles Mark J

Avg. Two Year Performance

No purchase track record
(38%) Avg. Sale Return
(18%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)(5%)(4%)(3%)0%
Purchase Success Rate1 of 21 of 20 of 20 of 20 of 2
Average Sale Return4%< 1%(8%)(< 1%)(38%)
Sale Success Rate2 of 21 of 20 of 21 of 21 of 2
Drugs » Biotechnology

CEO, CHAIRMAN OF BOARD, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 10.0K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--